Last deposits
-
-
-
-
Timothée David, Aude Mallavialle, Julien Faget, Lindsay B Alcaraz, Marion Lapierre, et al.. Anti-cathepsin D immunotherapy triggers both innate and adaptive anti-tumour immunity in breast cancer: Antibody-based immunomodulatory therapy of breast cancer. British Journal of Pharmacology, In press. ⟨hal-04295033⟩
-
-
Thomas Grinda, Alison Antoine, William Jacot, Paul-Henri Cottu, Thibault de la Motte Rouge, et al.. Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort. European Journal of Cancer, 2023, 189, pp.112935. ⟨10.1016/j.ejca.2023.05.023⟩. ⟨hal-04205902⟩
-
Emmanuel Deshayes, Eric Assenat, Laetitia Meignant, Manuel Bardiès, Lore Santoro, et al.. A prospective, randomized, phase II study to assess the schemas of retreatment with Lutathera® in patients with new progression of an intestinal, well-differentiated neuroendocrine tumor (ReLUTH). BMC Cancer, 2022, 22 (1), pp.1346. ⟨10.1186/s12885-022-10443-4⟩. ⟨hal-04238912⟩
-
-
-
Fulltext
Notices